156 related articles for article (PubMed ID: 33311579)
1. Emer Cooke.
Mullard A
Nat Rev Drug Discov; 2021 Jan; 20(1):12-13. PubMed ID: 33311579
[No Abstract] [Full Text] [Related]
2. Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development.
Baay M; Neels P
Front Immunol; 2021; 12():658783. PubMed ID: 33777056
[No Abstract] [Full Text] [Related]
3. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
Joffe S
JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
[No Abstract] [Full Text] [Related]
4. Being fair to participants in placebo-controlled COVID-19 vaccine trials.
Dal-Ré R; Orenstein W; Caplan AL
Nat Med; 2021 Jun; 27(6):938. PubMed ID: 33903751
[No Abstract] [Full Text] [Related]
5. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
6. COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine.
Neurosciences (Riyadh); 2021 Apr; 26(2):222-223. PubMed ID: 33814381
[No Abstract] [Full Text] [Related]
7. [Lightning fast development of pandemic vaccines in 2020].
Josefsdottir KS
Laeknabladid; 2020 Dec; 106(12):567. PubMed ID: 33252047
[No Abstract] [Full Text] [Related]
8. The UK has approved a COVID vaccine - here's what scientists now want to know.
Ledford H; Cyranoski D; Van Noorden R
Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
[No Abstract] [Full Text] [Related]
9. Equitable global access to coronavirus disease 2019 vaccines.
Schwartz JL
BMJ; 2020 Dec; 371():m4735. PubMed ID: 33323384
[No Abstract] [Full Text] [Related]
10. Messengers of hope.
Nat Biotechnol; 2021 Jan; 39(1):1. PubMed ID: 33376248
[TBL] [Abstract][Full Text] [Related]
11. Transforming vaccine development.
Black S; Bloom DE; Kaslow DC; Pecetta S; Rappuoli R
Semin Immunol; 2020 Aug; 50():101413. PubMed ID: 33127296
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccines approved in the European Union: current evidence and perspectives.
Bellino S
Expert Rev Vaccines; 2021 Oct; 20(10):1195-1199. PubMed ID: 34338126
[No Abstract] [Full Text] [Related]
13. South Africa responds to new SARS-CoV-2 variant.
Makoni M
Lancet; 2021 Jan; 397(10271):267. PubMed ID: 33485437
[No Abstract] [Full Text] [Related]
14. Innovators target vaccines for variants and shortages in global South.
Sheridan C
Nat Biotechnol; 2021 Apr; 39(4):393-396. PubMed ID: 33731936
[No Abstract] [Full Text] [Related]
15. Talk of the town in 2021: Covid-19 vaccines likely take centre stage.
Höglund P
Scand J Immunol; 2021 Jan; 93(1):e13014. PubMed ID: 33372339
[No Abstract] [Full Text] [Related]
16. Answering Key Questions About COVID-19 Vaccines.
Goodman JL; Grabenstein JD; Braun MM
JAMA; 2020 Nov; 324(20):2027-2028. PubMed ID: 33064145
[No Abstract] [Full Text] [Related]
17. Rationing of Civilian Coronavirus Disease 2019 Vaccines While Supplies Are Limited.
Zimmerman RK; South-Paul JE; Poland GA
J Infect Dis; 2020 Nov; 222(11):1776-1779. PubMed ID: 32894861
[No Abstract] [Full Text] [Related]
18. COVID-19 vaccines: one step towards the beginning of the end of the global impact of the pandemic.
Cook TM; Farrar JJ
Anaesthesia; 2021 Apr; 76(4):435-443. PubMed ID: 33316853
[No Abstract] [Full Text] [Related]
19. Covid-19 vaccination during Ramadan.
Mughal F
BMJ; 2021 Apr; 373():n862. PubMed ID: 33795237
[No Abstract] [Full Text] [Related]
20. The race for a COVID-19 vaccine.
Lavigne SE
Can J Dent Hyg; 2020 Oct; 54(3):107-109. PubMed ID: 33240370
[No Abstract] [Full Text] [Related]
[Next] [New Search]
